Connection
Robert McQueen to Decision Making
This is a "connection" page, showing publications Robert McQueen has written about Decision Making.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.313 |
|
|
|
-
Zemplenyi A, DiStefano MJ, Zheng H, Campbell JD, McQueen RB. Expanding the definition of unmet medical need: Findings from a multistakeholder workshop. J Manag Care Spec Pharm. 2026 Oct; 32(10-c Suppl):S11-S20.
Score: 0.142
-
Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD. Value of Information in Asia: Concepts, Current Use, and Future Directions. Value Health Reg Issues. 2016 May; 9:99-104.
Score: 0.069
-
McQueen RB, Nair KV, Vollmer TL, Campbell JD. Incorporating real-world clinical practice in multiple sclerosis economic evaluations. Expert Rev Pharmacoecon Outcomes Res. 2015; 15(6):869-72.
Score: 0.066
-
Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, Veenstra D, Whittington MD, Ollendorf DA. Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States. Pharmacoeconomics. 2019 11; 37(11):1321-1327.
Score: 0.022
-
Campbell JD, McQueen RB, Briggs A. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence. Ann Am Thorac Soc. 2014 Feb; 11 Suppl 2:S105-11.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|